RPD
February 3, 2026

House and Senate extend the rare pediatric disease priority review voucher program to 2029

The House and Senate have passed the Mikaela Naylon Give Kids a Chance Act to extend the rare pediatric disease priority review voucher program to 2029. The bill is now on the Presidents desk to be signed into Law. Amazing news for patients and the industry.

Track every
FDA Priority Review Voucher Program.

Stay updated
Thank you!
Oops! Something went wrong while submitting your email.

This webpage has been compiled from manually reviewing thousands of documents from the U.S. Securities and Exchange Commission (SEC), U.S. Food and Drug Administrations (FDA), Federal Register, press releases and financial records. The information on this page has been compiled from publicly available sources only and does not include any undisclosed PRV issuance's, transactions or redemptions.

Stay in the loop

News, analysis, and insights from the world of Priority Review Vouchers.

Thank you!
Oops! Something went wrong while submitting your email.